NCT02585726View on ClinicalTrials.gov

Lake Washington Vascular VenaSeal™ Post-Market Evaluation (WAVES)

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Venous Reflux
Interventions
DEVICE

SP-402 VenaSeal™ Closure System

A medical device kit consisting of seven delivery tools and the proprietary VenaSeal™ Adhesive (Medtronic Cardiovascular, Santa Rosa, CA). The device is used to treat venous reflux in lower extremity superficial truncal veins for subjects in the treatment arm..

Trial Locations (1)

98004

Lake Washington Vascular, PLLC, Bellevue

All Listed Sponsors
collaborator

Syntactx

NETWORK

lead

Lake Washington Vascular

OTHER

NCT02585726 - Lake Washington Vascular VenaSeal™ Post-Market Evaluation (WAVES) | Biotech Hunter | Biotech Hunter